M. F. W. Gee, E. B. De Vol, H. R. Levy, A. T. Boltyenkov, Sanyal. AJ. Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.71077. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.71077?af=R
M. F. W. Gee, E. B. De Vol, H. R. Levy, A. T. Boltyenkov, & Sanyal. AJ (2026). Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.71077
M. F. W. Gee, et al. “Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.71077.
@article{Gee2026,
title = {Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply},
author = {Gee, M. F. W. and Vol, E. B. De and Levy, H. R. and Boltyenkov, A. T. and AJ, Sanyal.},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.71077},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.71077?af=R}
}